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Scope of the problem
Sexually transmitted infections (STIs), including HIV, contribute greatly
to the global health burden each year. In 2007 it was estimated that there
were 2.5 million new cases of HIV worldwide, including 2.1 million adults
and 420,000 children [1]. Furthermore each year it is estimated that there
are more than 300 million new cases of treatable STIs including gonorrhea,
chlamydia, syphilis, and trichomonas [2]. Although the situation in the
United States is somewhat diﬀerent from that in the developing world,
STIs continue to be a major public health concern. Despite targeted preven-
tion eﬀorts, in 2006 there were almost 37,000 new diagnoses of syphilis,
more than 350,000 new cases of gonorrhea, and more than 1 million new
cases of chlamydia [3]. Although the overall rate of new HIV diagnoses
has stabilized in the United States at about 35,000 to 40,000 per year since
2001 (based on the 33 states and United States dependent areas with conﬁ-
dential, name-based HIV infection reporting), the number of persons living
with HIV/AIDS, which was estimated exceed 430,000 by the end of 2005,
increases annually [4].
Both globally and in the United States, women are aﬀected dispropor-
tionately by STIs and HIV. Globally, women now comprise 48% of the
adults living with HIV [5]. In the United States, the incidence of gonorrhea
and chlamydia are higher in young women than in men of the same age
group: among 20- to 24-year-olds the incidence of chlamydia is 2797 per
100,000 for women versus 857 per 100,000 for men, and the incidence of
gonorrhea is 606 per 100,000 for women versus 454 per 100,000 for men [3].
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620 PIPERMinority women in the United States are aﬀected to an even greater extent
than their non-Hispanic white counterparts. Gonorrhea rates among
African American women (618 per 100,000) far exceed those of both
non-Hispanic white women and Hispanic women (44 and 85 per 100,000,
respectively). Chlamydia, syphilis, and HIV also are diagnosed more
commonly in African American and Hispanic women than they are in non-
Hispanic white women in the United States [3].Preventing sexually transmitted infections via systematic initiatives
Because of the signiﬁcant public health impact of STIs and HIV, nu-
merous attempts have been made to reduce the incidence and prevalence
of these infections. These eﬀorts can be grouped into several major cate-
gories: systematic initiatives, community-level programs, and individual
or small-group interventions. Systematic initiatives may occur at the local,
regional, national, or even international level and have included ap-
proaches such as implementing a program to encourage rapid diagnosis
and treatment of curable STIs, public health education eﬀorts, identiﬁca-
tion of clusters of new infections and enacting targeted interventions in
those cluster communities, and identiﬁcation of barriers to the acquisition
of health care with targeted interventions to remove or reduce those bar-
riers. Challenges faced by systematic initiatives include accessibility to
those at highest risk, timeliness, comprehensiveness, ability to be imple-
mented through functional health care systems, and ability to be moni-
tored for eﬃcacy.
Researchers in the United Kingdom recently reviewed the eﬀectiveness of
a series of systematic initiatives targeting STI/HIV prevention on a national
level [6]. They focused on ﬁve speciﬁc initiatives enacted between 1999 and
2004: universal oﬀering of an HIV test during prenatal care, oﬀering volun-
tary counseling and testing for HIV to all ﬁrst-time STI clinic attendees,
oﬀering hepatitis B vaccine to all men who have sex with men at their ﬁrst
STI clinic attendance, reducing waiting times at STI clinics, and implement-
ing programs for the early detection of asymptomatic chlamydia. For the
two initiatives for which there were prior data, signiﬁcant improvements
were noted in the selected outcome metrics. With regard to prenatal HIV
testing, the proportion of HIV-infected women diagnosed before delivery
increased from 40% in 1998 (before the 1999 implementation) to 88% in
2003. Rates of acceptance of voluntary counseling and testing for STI clinic
attendees increased from 40% in 2001 to 56% in 2003 after implementation
of that initiative in 2002. Most of these systematic initiatives, however, focus
on secondary prevention of STIs and HIV through early detection and treat-
ment to prevent secondary spread (for curable STIs) or early detection to
reduce secondary transmission via pre-exposure prophylaxis (prevention
of mother-to-child transmission of HIV). Although systematic initiatives
can be implemented broadly and have potentially widespread impact, in
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inadequate to stem the current STI/HIV epidemic.Preventing of sexually transmitted infections
via community-based programs
Primary prevention of STIs including HIV requires interventions targeted
toward high-risk groups on a small-group or individual basis as well as dif-
ferent types of interventions for those at lower (but still not negligible) risk.
Many of the interventions aimed at lower-risk individuals are implemented
through community-based programs. These programs include educational
campaigns, assuring that condoms are widely available (and aﬀordable),
and providing access to STI testing/treatment and counseling. For example,
a community-based program for a college community might involve
improving access to condoms by installing dispensers in campus restrooms,
providing STI education (through posters, ﬂyers, e-mail information, and
Web-based information and/or seminars), and making students aware of
the availability of STI care and counseling at the Student Health Center.
Another example would be providing condoms at community venues
commonly used for commercial sex work.
Unfortunately, the analysis of the eﬀectiveness of community-based
programs for STI prevention often is problematic. Increased outreach
eﬀorts often result initially in an increase in the diagnosis of STIs, and
frequently the true baseline rate in the community before the intervention
is unknown. Condom distribution may result in increased availability of
condoms but does not ensure their correct and consistent use. Educational
campaigns are of value only if the information is put into action, resulting in
the reduction of risky behavior or more rapid entry to the health care system
for diagnosis and treatment. Although the intervention occurs in a more
widespread fashion, community-based programs attempt to achieve their
goals essentially by encouraging individuals to change their behavior or to
access health care earlier for diagnosis and treatment to prevent secondary
spread. The intervention may be conducted using community resources, but
the change must occur at the individual level.Background on behavioral interventions for preventing sexually
transmitted infections
Because the acquisition of STIs is based on sexual risk behavior, any pri-
mary prevention intervention for STIs must impact individual risk behavior.
Although public health initiatives (such as the systematic initiatives and com-
munity-based programs described earlier) usually are addressed at least min-
imally in the American medical education curriculum, the term ‘‘behavioral
intervention’’ is bound to strike fear into the hearts of many physicians be-
cause it is a matter that they feel ill prepared to address. Even though many
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interventions targeting weight loss or smoking cessation, behavioral interven-
tions targeting such sensitive areas as sexual risk behaviors may be outside
their comfort zone. Training medical students in the counseling skills needed
to obtain sensitive sexual information and to provide eﬀective STI prevention
counseling has long been identiﬁed as a signiﬁcant gap in the medical educa-
tion system, but withmany competing priorities for the limited classroom and
clinical hours, this gap often goes unﬁlled [7]. Most of the limited time set
aside for STI training in medical school curricula is devoted to diagnosis
and treatment; little time is left for education about prevention as a whole
or speciﬁcally for education concerning behavioral interventions for STI
prevention. This lack of emphasis in the medical education system along
with the resulting lack of knowledge of and experience with behavioral inter-
vention (and with behavioral science as a whole) has created a sense among
many physicians that these subjects are somewhat mystical or incomprehen-
sible and as such should not be considered solid science.
Providers of STI preventive care regard the behavioral science theory
behind interventions for STI prevention as being vague, abstract, boring,
and irrelevant [8]. Interestingly, when a group of STI prevention providers
participating in training sessions at a Centers for Disease Control and
Prevention (CDC)-sponsored Sexually Transmitted Disease (STD)/HIV
Prevention Training Center were asked about factors aﬀecting STI risk
behavior, they consistently identiﬁed most of the concepts that form the
basis for the behavioral science behind STI prevention interventions
(ie, recognition and acknowledgment of individual risk and recognition of
internal and external factors that inﬂuence an individual’s ability to alter
their risk status) [8]. Using the Theoretic Domains model, instructors assis-
ted the participants in categorizing the factors they identiﬁed as important
for inﬂuencing behavioral change into ﬁve theoretic domains: risk appraisal,
self-perceptions, emotion and arousal, relationships and social inﬂuence,
and structural and environmental factors. Even providers who had no prior
formal education in behavioral science had an intuitive understanding of the
factors that inﬂuence behavioral change. Before completing this exercise,
many of these providers would have assumed that behavioral science was
beyond their comprehension; clearly, that assumption is not valid. There re-
mains a need for better communication between the individuals performing
research on behavioral interventions to prevent STIs and those in the public
health ﬁeld currently engaged in STI prevention activities to move the ﬁeld
forward at the most expeditious pace.Development of behavioral interventions for preventing sexually
transmitted infections
Why is behavioral science and behavior change theory an essential part of
intervention development? Even though, technically, having a care provider
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intervention, that admonition is likely to be no more eﬀective than saying,
‘‘You should stop smoking,’’ or, ‘‘You should lose weight.’’ To have much
impact, a STI prevention intervention needs to address multiple aspects of
sexual risk behavior. Theoretic models of behavior change provide the
framework for addressing risk reduction in amore holistic fashion. A number
of diﬀerent theoretic models have been applied in STI prevention interven-
tions, and, as described earlier, they share common themes including recog-
nition of risk, desire to reduce risk, recognition of barriers to change, and
identiﬁcation/implementation of ways to eliminate or reduce those barriers
to facilitate change.
One example of the adaptation of a speciﬁc theoreticmodel into a successful
STI prevention intervention is Project SAFE (Sexual Awareness for Every-
one) [9]. The Project SAFE intervention is based on an adaptation of the
AIDSRisk ReductionModel. The three stages of behavioral change incorpo-
rated into the Project SAFE intervention are (1) recognition of one’s individ-
ual risk, (2) commitment to making changes to reduce that risk, and (3)
acquiring the skills needed to implement changes to reduce risk. Indeed, the
ﬂow of the Project SAFE three-session intervention (one 3-hour session per
week for 3 consecutive weeks) is based on spending each of the weekly sessions
on one of these aspects of behavioral change. The ﬁrst session focuses on rec-
ognition of risk, including raising awareness that minorities are dispropor-
tionately aﬀected by STIs and HIV, addressing commonly held beliefs/
myths about STIs (eg, the ability to determine which men ‘‘look safe’’), and
providing information on STI acquisition, symptoms (or lack thereof), treat-
ment, and long-term impact (including the impact of untreated STIs on fertil-
ity and the impact of STI/HIV on families). The second session focuses on
commitment to change, providing information on prevention of future STIs
with an emphasis on the importance of early and complete treatment for
both partners, teaching participants how to ask prospective partners about
risk behaviors, teaching techniques of erotic condom placement, and discus-
sing individual empowerment to make decisions and overcome barriers to re-
ducing sexual risk. The third session focuses on the acquisition of the skills
needed to make changes to reduce risk, including increasing communication
skills regarding condom negotiation and other sexual issues (through the
use of videos, group discussion, and role playing), increasing skills in erotic
condom application, goal setting, and encouragement in building a support
network for risk reduction. In a randomized, controlled trial, minority women
who received this culture- and gender-speciﬁc behavioral intervention were
signiﬁcantly less likely to have a new infection with gonorrhea or chlamydia
during the 12 months of follow-up than women in the control group who re-
ceived standard (15- to 20-minute) STI prevention counseling (see the ex-
tended description under Major Trials: Project SAFE later in this article) [9].
Many diﬀering types of intervention have been applied to STI preven-
tion. Some, such as Project SAFE, used small-group interventions targeted
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group interventions with diverse participants. Others have used individual
one-on-one counseling either inside a health care setting (doctor’s oﬃce or
clinic) or in the community. The intervention facilitator also varied greatly,
ranging from physicians in private practice, academic researchers, or exten-
sively trained/experienced research staﬀ to relatively minimally trained/
experienced peer educators selected from the target community. The use
of each type of facilitator has advantages and disadvantages. Physicians
may have an established relationship with the patient and typically hold
a position of respect but have very limited time and frequently have little
training in or comfort with behavioral intervention. Academic researchers
understand the behavioral theory and its application to STI prevention
but may have little in common with the individuals with whom they are
interacting and thus may have diﬃculty connecting with them. Trained,
experienced research staﬀ probably have the most favorable advantage/
disadvantage ratio, because they have the advantage of understanding the
development of the intervention and the theory behind it and also may
have experience working with those at high risk and understanding the chal-
lenges they face in daily life. Peer educators clearly have the best comprehen-
sion of the social and economic pressures faced by community members at
risk but unfortunately also have the least understanding of the intervention
process. In theory, facilitator demographics also could aﬀect the success of
intervention. Project SAFE chose to use Hispanic facilitators for Hispanic
group sessions and African American facilitators for African American
sessions based on community input before implementation. Other studies
have chosen not to match facilitators with participants and have described
no impact of facilitator demographics on intervention outcome [10].Trial design for the testing of interventions for preventing sexually
transmitted infections
Once an intervention has been designed to reduce STI acquisition, it must
be tested to determine whether it has any impact. Although for a long time
some practitioners believed that any intervention must do some good and
should be implemented without testing, well-intentioned interventions occa-
sionally have resulted in harm, and many others have not been harmful but
have had no beneﬁt. The transition of an intervention from research/
development into widespread implementation is quite costly. Thus the
human and ﬁnancial resources necessary for this transition to occur must
be invested in the most eﬃcacious interventions. Factors to be considered
in testing an intervention include the target population, the length and
type of follow-up to be used, and the facilities/staﬃng required to implement
and assess the eﬃcacy of the intervention. The target population may be
determined by the intervention design (eg, only women, only men, only
certain types of high-risk individuals) or by convenience, availability, or
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the background rates of the desired outcome must be high enough in the
targeted population to allow a reasonable chance of ﬁnding a signiﬁcant
reduction in the intervention group as compared with the control group.
Interventions to reduce STIs frequently recruit participants from STI clinics
because this method ensures that individuals who are at higher-than-average
risk for future STI acquisition will be enrolled.
Another key factor in trial design is determining the duration of the
follow-up period. The number of new infections detected clearly is aﬀected
by the duration of follow-up, but a more important issue is the potential for
diminution or acceleration of intervention impact over time. Intervention
participants may be very motivated to make risk-reduction changes immedi-
ately after the intervention, but that enthusiasm may wane as time passes.
Conversely, it may take time for participants (particularly women) to disen-
gage themselves from a risky situation and move toward lower risk. The
follow-up period needs to be long enough to detect these trends but must
be balanced by the cost and diﬃculty of retaining high-risk participants
over extended periods of time.
The type of follow-up may vary based on the outcome measures used and
whether examinations are required for specimen collection. Using STI
acquisition as an outcome requires the ability to perform STI testing in
a timely fashion whenever the participants suspects infection, not just at
the time of routine visits. This requirement aﬀects the facilities and staﬃng
needed to perform the study. The resources needed to collect behavioral
data by face-to-face interview or by a computer-assisted technique must
be considered also. All totaled, large-scale behavioral intervention trials
are quite costly, complex, and diﬃcult to implement, regardless of the
type of behavior targeted by the intervention. STI prevention interventions
have some factors (such as the potential need for pelvic examinations to
collect specimens) that may make their trials even more complicated than
those of other types of interventions.Outcome measures for testing of interventions for preventing sexually
transmitted infections
When comparing trials of behavioral interventions to reduce STIs, another
key feature to evaluate is the outcome measures selected. Primary outcome
measures in these trials typically can be categorized as biologic outcomes or
behavioral outcomes. Biologic outcomes include documented new infection
with STI organisms and the presence of biomarkers for unprotected inter-
course. Behavioral outcomes commonly used include self-reported condom
use (measured in multiple ways), the number of new partners, the risk status
of partners, and the use of alcohol or drugs in conjunctionwith sexual activity.
As mentioned earlier, condom use can be determined and analyzed in
many diﬀerent ways. The time frame queried may be the last sex act, the
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with all partners, with the main partner, with casual partners, or collection
of data separately on each partner in the last 3 or 6 months. Other important
aspects of condoms use are consistency and correct use (placement before
any genital contact, covering the entire penis, use of the correct size with
appropriate lubricants, and securing the condom during withdrawal). Com-
mon problems with condom use often are related to incorrect use. Slippage
or dislodgement into the vagina often is a result of applying the condom
only partway up the penis and failure to secure the condom during with-
drawal. Breakage may be caused by failure to leave room at the tip of the
condom, use of the wrong size condom, or use of an inappropriate lubricant
that accelerates degradation (oils or petroleum jelly). Infection also may
result from genital contact before condom application.
There has been a great deal of discussion during the past 15 years as to
whether the use of a biologic outcome was preferable to the use of a behav-
ioral outcome. Experts in the ﬁeld have argued eloquently for one or the
other, in the literature and at symposia and conferences. In the end, if the
goal of the intervention is to reduce STI acquisition, direct measurement
of STI acquisition rates is logically the most appropriate outcome measure.
Reduced STI acquisition most commonly is the goal of an interventional
trial, but complete ascertainment requires the resources to collect samples
for STI testing at routine and problem-oriented visits. Until recently,
frequent pelvic examinations or urethral swabs were required to collect spec-
imens, creating a signiﬁcant burden for both participants and research staﬀ.
The advent of urine-based STI testing via nucleic acid ampliﬁcation allowed
biologic outcomes to be obtained without a clinician examination. This
advance made collection of a biologic outcome much more feasible in
large-scale trials and in studies conducted outside a clinic setting.
When the goal of the intervention is primarily to alter risk behavior (with
or without an impact on STI acquisition), measurement of self-reported
behavior would seem to be the most valid primary outcome. Currently,
however, behavioral measures are used more commonly as a secondary out-
come to help explain the mechanisms by which the intervention aﬀected STI
acquisition rates. Unfortunately, there is no direct measure of risk behaviors
beyond the use of self-reporting, which may lack precision for several
reasons, one of which is the dependence on participants remembering details
of sexual activity that occurred days or months earlier. Recall bias can be
reduced by the use of diaries or other methods to improve memory or by
limiting questions to recent events (eg, the last act or the last 10 acts, as
opposed to the last 3 or 6 months). Even so, recall bias remains a signiﬁcant
problem. Diaries often go unused or are ﬁlled out on the way to the appoint-
ment (commonly while sitting in the waiting room). The participants at
highest risk are those who have many partners and frequent sexual activity,
and these participants are the least likely to remember when and with whom
they used (or did not use) condoms and other details of sexual activity.
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giving the answer the interviewee thinks the interviewer would like to hear,
even if it is not a valid response to the question. Social desirability bias is an
important confounding factor whenever face-to-face interviews are used to
collect sensitive information. Self-administered pen-and-paper interviews
sometimes were used previously to limit this bias, but this technique
required respondents to have adequate literacy to read and respond to the
questions. Recently, attempts have been made to use advances in informa-
tion technology to minimize desirability bias in collecting sensitive informa-
tion. The use of computer-based interviewing with the inclusion of audio for
the questions (ACASI) has been adopted widely for the collection of sensi-
tive data and allows collection even in populations with lower literacy rates.
ACASI also can be used in settings with multiple language needs, because
the questions can be prerecorded in multiple languages and selected as
needed. Responses also can be displayed pictorially on the computer screen
for selection by the participant. Other uses of technology to improve the
collection of behavioral data include the use of telephone diaries in which
participants call frequently to report events to computerized databases as
they occur instead of waiting to report them at scheduled visits. Research
currently underway is attempting to develop devices that can detect sexual
intercourse and can determine whether a condom was used. Obviously
this approach would be quite invasive and never could replace self-reporting
in large-scale trials.Interventions for preventing sexually transmitted infections: what has been
done thus far
It would be impossible within the scope of this article to discuss every
behavioral intervention that has been studied for STI prevention in women
worldwide. Instead this article focuses on the diﬀering types of interventions
studied (with illustrative examples) and on the major intervention trials that
are cited most commonly in the literature. As mentioned earlier, behavioral
interventions can vary from the simple words, ‘‘You should stop having risky
sex,’’ to multisession interventions using audiovisual aids, role-playing, and
skills-building. An illustrative example of a simpler form of intervention using
face-to-face brief advice from a physician was studied inAustralia [11]. It con-
sisted of brief behavioral advice provided at the time of a routine visit to a fam-
ily practitioner’s oﬃce to individuals who agreed to participate in the study
and who completed a survey of sexual risk behaviors while waiting to be
seen by the doctor. The speciﬁc advice was based on the patient’s response
to the questions: ‘‘Do you think you are at risk for a sexually transmitted dis-
ease? For an unwanted pregnancy? For hepatitis B or C?’’ Each participant
randomly assigned to receive brief advice also was given a ‘‘safe sex’’ pack
that included condoms and educational materials. Those randomly assigned
to control conditions were asked about smoking as a health risk factor. All
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were 312 participants enrolled (156 each in the intervention and control
groups); 237 of these participants agreed to participate in a follow-up survey
in 3 months, and 156 participants (50% of enrollees) actually completed and
returned the questionnaire. At the time of the follow-up survey, 68% of the
participants in the brief-advice group recalled having received information
about safe sex from their doctor, and only 58% remembered having been
given a package of educational material. A major focus of the questionnaire
was sexual behaviors with a new partner. Only 11 intervention participants
and 13 control participants had acquired a new partner in the 3 months since
their visit. Although the results obviously were limited by small numbers,
equivalent proportions in both groups had discussed safe sex with their new
partner (36% versus 38%) and had used a condom for their ﬁrst sexual
encounter with the new partner (73% versus 77%). Interestingly, between
enrollment and follow-up, perceptions of risk seemed to increase more in
the control group than in the intervention group.Major trials: project RESPECTProject RESPECT is an excellent example of a more intense individual
face-to-face intervention and is one of the major trials from the last 15 years
[12]. Project RESPECT was conducted at ﬁve public health STD clinics in
large cities in the United States between July 1993 and September 1996.
It enrolled 5758 heterosexual men and women who presented to the clinics
for STD testing and assigned them randomly to one of three interventions.
Participants in Arm 1 received four individual intervention sessions, the ﬁrst
lasting 20 minutes followed by three 60-minute sessions. Participants in Arm
2 received two 20-minute intervention sessions, the ﬁrst of which was the
same as he ﬁrst session of Arm 1. Participants in Arm 3 received two
5-minute sessions of didactic messages similar to those commonly provided
in a STD clinic. Participants in Arms 1 through 3 were requested to return
for follow-up at 3, 6, 9, and 12 months with testing for gonorrhea and chla-
mydia. Participants in the fourth arm received the same didactic messages as
those in Arm 3 but had no scheduled follow-up. Arm 4 was an attempt to
evaluate the intervention eﬀect of repeated clinic visits and contact with
the research staﬀ. An attempt was made to contact Arm 4 participants after
12 months to ask about condom use. Any time participants from any arm
presented to the clinic (for a scheduled visit or for a problem), they under-
went testing for gonorrhea and syphilis in accordance with the usual clinic
routine. This approach allowed the collection of infection data from the
Arm 4 participants and more complete ascertainment of infections in the
other arms. All interventions were provided by counselors and clinicians
in the STD clinics.
The primary outcome measure for Project RESPECT was acquisition of
gonorrhea, chlamydia, syphilis, or HIV during follow-up. The secondary
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intercourse during the past 3 months (no unprotected vaginal sex). Of the
4328 participants randomly assigned to Arms 1 through 3, only 51%
returned for all four follow-up visits, but 81% returned for at least one fol-
low-up visit, and 66% returned for the 12-month visit. At the 12-month fol-
low-up visit, acquisition of a new STI was less common in Arms 1 (11.5%)
and 2 (12%) than in Arm 3 (14.6%). Comparison of the unscheduled (prob-
lem) visits by participants in Arms 3 and 4 revealed no signiﬁcant diﬀerences
in rates of acquisition of gonorrhea or syphilis (3.3% versus 4.1%). With
regard to the secondary outcome, having had no unprotected vaginal inter-
course was reported more commonly by participants in Arms 1 and 2 than
by participants in Arm 3 at 3 and 6 months, but condom use increased for
all groups over time, and the diﬀerences between intervention arms had
disappeared by 9- and 12-months’ follow-up.Major trials: project SAFEProject SAFE is a good example of a small-group intervention [9]. The
Project SAFE intervention has been used in two major trials conducted in
San Antonio, Texas. The ﬁrst, Project SAFE, enrolled 617 minority women
(424 Mexican-American and 193 African American) who had an active, cur-
able STI. Of the participants, 313 were assigned randomly to receive the
three-session small-group intervention, and 304 received standard, brief
risk-reduction counseling. The women randomly assigned to the interven-
tion group returned for three weekly 3-hour sessions with women of their
own ethnicity. The facilitator was an experienced member of the research
staﬀ of the same ethnicity of the participants. Ninety percent of the interven-
tion group attended at least one session, and 75% attended all three
sessions. All participants were scheduled for follow-up at 6 and 12 months
and were asked to return to the research clinic for testing any time they had
suspicion of infection. Retention rates at 6 and 12 months were 82% and
89% and did not diﬀer between intervention and control groups.
The primary outcome measure for Project SAFE was the acquisition of
a new infection with gonorrhea or chlamydia over 12 months of follow-
up. Rates of new infection were signiﬁcantly lower in the intervention group
in both the 0- to 6-month visit windows (11.3% versus 17.2%; P ¼ .05) and
the 6- to 12-month visit windows (9.1% versus 17.7%; P ¼ .008).
At 12 months there was a 38% reduction in the rate of new infections in
the intervention group (16.8%) compared with the control group (26.9%;
P ¼ .004). Secondary outcome measures included behavioral factors
addressed by the intervention. Women in the intervention group were less
likely to be noncompliant with their STI treatment (including avoidance
of intercourse until the partner was treated), to have multiple partners, or
to engage in high-risk sex. A subsequent, more extensive analysis of risk
behaviors addressed by the intervention that may have contributed to the
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who acquired a new infection during follow-up and that were less common
in the intervention group [13]:
1. Having unprotected sex with an untreated or incompletely treated
partner (noncompliance)
2. Waiting less than 3 months to acquire a new sexual partner (rapid
partner turnover)
3. Not practicing mutual monogamy
4. Never having used condoms with a casual partner or a combination of
ﬁve or more unprotected acts in 3 months and problematic condom use
(unsafe sex)
5. Douching after intercourse.Major trials: project SAFE 2The second trial of the Project SAFE intervention, Project SAFE 2, used
the standard intervention and control arms from Project SAFE but added
a third enhanced intervention arm in which women received the intervention
and were oﬀered the option of attending monthly support group meetings
for 6 months following the intervention [14]. In addition to conﬁrming the
results of the prior study and determining the impact of oﬀering support
group meetings, Project SAFE 2 sought to evaluate the duration of interven-
tion eﬀect for a longer follow-up period with follow-up initially scheduled
for 2 years and subsequently extended to 5 years. (The results for years
2–5 results are still in analysis.) A total of 775 minority women were enrolled
(585 Mexican-American and 190 African American women); 262 were
assigned to the enhanced group (intervention plus support group meetings);
237 were assigned to the standard intervention; and 276 were assigned to the
control group. In the two arms assigned to receive the intervention, 96% of
the participants attended at least one session, and 86% attended all three
sessions. Of the women oﬀered support groups, 63% chose not to attend,
37% attended one meeting, and 26% attended more than one meeting.
Retention rates at 12 and 24 months were 91.4% and 91.2% and did not
diﬀer between groups.
The primary outcome measure for Project SAFE 2 was the acquisition of
a new infection with gonorrhea or chlamydia during follow-up. Both inter-
vention groups had signiﬁcantly lower rates of new infection than the
control group when adjusted for drug and alcohol abuse (Table 1). Women
who attended the support group meetings had the lowest rate of new infec-
tions in the ﬁrst year, in the second year, and for the cumulative 2-year
follow-up period, with a 63% reduction in the ﬁrst year as compared with
the control group. Factors addressed in the intervention that were associ-
ated with infection rates and that diﬀered among the study groups included
having unprotected sex with an untreated or incompletely treated partner
and having more than one partner in either year one or year two.
Table 1
Primary outcome analysis of Project SAFE 2a
Group
Follow-up period
0–12 Months (n ¼ 709) 12–24 Months (n ¼ 703) 0–24 Months (n ¼ 690)
Adjusted infection
rates (%)
Odds ratio (95%
conﬁdence interval)
Adjusted infection
rates (%)
Odds ratio (95%
conﬁdence interval)
Adjusted infection
rates (%)
Odds ratio (95%
conﬁdence interval)
Control 26.8 d 23.1 d 39.8 d
Standard
intervention
15.7 0.51 (0.31–0.83) 14.7 0.57 (0.34–0.96) 26.2 0.54 (0.34–0.85)
Enhanced
intervention
15.4 0.50 (0.31–0.80) 14.8 0.58 (0.36–0.94) 23.7 0.47 (0.30–0.73)
Enhanced: attended
support groups
12 0.37 (0.19–0.74) 13.5 0.52 (0.27–0.99) 21.8 0.42 (0.24–0.76)
a Adjusted rates of acquisition of a new infection with gonorrhea and/or chlamydia over 12 and 24 months of follow-up in the enhanced (intervention plus
support groups) and standard (intervention alone) groups as compared with the control (brief counseling only) group. Project SAFE 2 enrolled 775 minority
women in San Antonio, Texas between March 1996 and June 1998. Results are presented as adjusted infection rates and odds ratio (95% conﬁdence interval).
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632 PIPERProject SAFE 2 was the ﬁrst trial of a behavioral intervention to prevent
STIs that continued follow-up for a second year. It previously had been
reported that retention rates and intervention eﬀects diminished over
time. In contrast, Project SAFE 2 was able to maintain excellent retention
rates in both years (91% each year), and the intervention eﬀect remained
signiﬁcant up to 24 months after intervention. Interestingly, infection rates
in all three randomized study groups were lower in the second year than in
the ﬁrst, and rates in both intervention groups remained signiﬁcantly
reduced as compared with the controls.Major trials: National Institute of Mental Health multisite trialThe last of the major intervention studies reported in the literature is the
National Institute of Mental Health (NIMH) multisite HIV prevention trial,
a small-group intervention study performed at 37 inner-city community-
based clinics in seven states [15]. Participants were assigned randomly to
the control group (participants received a 1-hour AIDS education session
including a videotape and a question-and-answer period) or to the interven-
tion group. The intervention consisted of seven 90- to120-minute HIV risk-
reduction sessions conducted twice weekly for single-gender groups of 5 to
15 participants. The intervention sessions were facilitated by experienced
male and female staﬀ members who underwent extensive training and certi-
ﬁcation before study initiation. The participants were recruited from STD
clinics (both men and women) and from primary care clinics (women
only). The NIMH study enrolled 3706 participants between January 1994
and February 1996; 1851 were assigned to the intervention group, and
1855 were assigned to the control group. All participants were interviewed
at baseline and at 3, 6, and 12 months of follow-up with urine testing for
gonorrhea and chlamydia at 12 months only. For the 2426 participants en-
rolled at STD clinics (65% of the total), an attempt was made to identify
new STI acquisition by chart abstraction in addition to the 12-month urine
screen. Participants assigned to the intervention group attended an average
of 5.2 of the seven sessions; 63% attended either six or seven sessions.
Ninety percent of the participants attended at least one follow-up visit,
and 79% attended the 12-month visit at which STI screening was
performed.
The NIMH trial listed ﬁve primary end points and two secondary end
points in the main study publication:
1. Self-reported unprotected intercourse in 90 days before visit
2. Self-reported consistent condom use in last 90 days before visit
3. Self-reported proportion of sexual acts in which a condom was used
4. STD reinfection rate from chart abstraction over the 12 months study
period (male STD clients only)
5. Point prevalence of gonorrhea and chlamydia at the 12-month visit
633PREVENTION OF SEXUALLY TRANSMITTED INFECTIONSThe secondary end points were self-reported STD symptoms in the last
90 days before visit and the incidence of gonorrhea over the 12-month study
period from chart abstraction for STD clients. Although the self-reported
sexual risk behaviors declined in both groups, the intervention group
reported less risky behavior during follow-up than the control group
(eg, more frequent condom use, higher proportion of condom use, and
greater likelihood of reporting consistent condom use). During follow-up,
STI symptoms were reported more commonly by the control group than
by the intervention group (35% versus 28%). In contrast, the rates of new
STD acquisition by chart review (9.4% versus 9.1%) and by urine screening
(2.8% versus 2.9% for chlamydia; 1.5% versus 0.9% for gonorrhea) did not
diﬀer between the intervention and control groups. This study is an example
of the conﬂict between those who favor behavioral outcomes and those who
argue for biologic outcomes. Even though self-reported sexual risk behav-
iors were reduced successfully in the intervention group, there was no
impact on STI acquisition as assessed in this study. The key issue, however,
was the suboptimal detection of new infections used in this study.Next steps: translation from research trials to public health impact
Behavioral interventions to prevent STI acquisition in heterosexual
women have been developed and implemented in research trials. Many trials
have resulted in reductions in self-reported sexual risk behaviors, and
several have resulted in reductions in STI acquisition during follow-up.
To have a signiﬁcant public health impact, these interventions must be
translated for widespread use. The CDC have been at the forefront of the
eﬀort to translate successful behavioral interventions from the research
arena to the public health domain for broad implementation.
In the mid-1990s, the CDC sponsored the development of a collection of
STI-prevention interventions aimed at adolescents and in 1996 published
their Program Archive on Sexuality, Health and Adolescence, a collection
of 13 behavioral interventions to reduce STIs in adolescents [16]. To build
on that experience, the CDC sponsored a second project to select a group
of successful behavioral interventions for adults and to provide all the
materials necessary to implement each of the interventions in a single pack-
age (ie, one package per intervention). The results of the HIV/AIDS Preven-
tion Program Archive (HAPPA) were published in 2001 [17]. The HAPPA
selection process included review by an expert scientiﬁc panel based on the
intervention having demonstrated a salutary eﬀect on HIV-related risk be-
havior in at least one subgroup of adults in at least one site in the United
States. The scientiﬁc panel reviewed 32 intervention programs and selected
18 for potential inclusion in their ‘‘promising prevention programs in
a box.’’ Following discussions with the developers or current holders of
the 18 selected interventions, HAPPA was able to acquire 10 of the pro-
grams for packaging and distribution. (Seven of the other eight programs
634 PIPERselected were available already from their developer; the eighth was deemed
by its developer to be obsolete) After the intervention packages were devel-
oped, each was ﬁeld tested in settings that diﬀered from those in which it
was initially tested to verify usability, clarity, and appeal to practitioners.
When package development was completed, the CDC further assisted in
the dissemination of these interventions by providing training for local
STI prevention providers at CDC-funded Behavioral Intervention Training
Centers in Oakland California; Denver, Colorado; Rochester, New York;
and Dallas, Texas. These four centers are a part of the National Network
of STD/HIV Prevention Training Centers funded by CDC.
One important aspect of translation from the research setting to diverse
implementation is adaptation to ﬁt the community of interest. Solomon and
colleagues [18] recently reviewed the importance of maintaining a scientiﬁc
basis for the necessary adaptation to avoid loss of eﬃcacy. The ﬁve steps
to research-based adaptation of an intervention are to
1. Identify the desired target population and community context
2. Select an intervention program that best matches the population and
context
3. Retain ﬁdelity to the core of the intervention program
4. Identify and reduce conﬂicts between the selected program and the
target context
5. Document the changes made and evaluate the outcome of the adapted
intervention to allow further adaptation/ﬁne tuning as needed
Using this approach, an intervention designed for Mexican-American
women in San Antonio feasibly could be adapted for Latino women in other
parts of the country based on community assessment and use of appropriate
cultural context.Summary
Alteration of individual sexual risk behavior is key to preventing sexually
transmitted infections including HIV. Individual or small-group behavioral
interventions are the most eﬃcacious approach to altering individual sexual
risk behavior. Successful behavioral interventions have been designed,
developed, and tested in their target populations and have resulted in reduc-
tions in risk behavior and/or acquisition of STIs. Eﬀorts are under way to
implement those successful interventions more broadly by translation for
use in diverse public health settings. This process of development, validation
in randomized controlled trials, and subsequent dissemination to popula-
tions in need will be completed when the ongoing implementations result
in feedback to the developers to allow the development of second-generation
interventions that have been improved based on real-world experience.
At that point, the process of the scientiﬁc development of behavioral inter-
ventions to prevent STIs will have come full circle. It is hoped that
635PREVENTION OF SEXUALLY TRANSMITTED INFECTIONSbehavioral interventions soon will be recognized by all medical practitioners
as another scientiﬁcally validated tool to prevent disease and suﬀering.References
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